This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Omic Smap Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Ji Sun Hwang
Introduction
Ji Sun Hwang is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His work focuses on developing compounds that exhibit high inhibitory abilities on specific enzymes related to cancer progression.
Latest Patents
One of Ji Sun Hwang's key patents is for a Quinazoline-2,4-diamine derivative and pharmaceutical composition aimed at preventing or treating cancer. This invention includes a compound, a stereoisomer, a hydrate, or a pharmaceutically acceptable salt that demonstrates a high inhibitory ability on euchromatic histone-lysine N-methyltransferase 2 (EHMT2). This compound holds promise for effective cancer treatment.
Career Highlights
Ji Sun Hwang is currently associated with Omic Smap Inc., where he continues to innovate in the pharmaceutical sector. His dedication to research and development has positioned him as a valuable asset in the fight against cancer.
Collaborations
He collaborates with talented individuals such as Jung Jin Hwang and Sang Eun Park, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Ji Sun Hwang's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions are paving the way for new treatments that could significantly improve cancer care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile